These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37705586)

  • 1. Transformation of HHV-8-negative idiopathic multicentric Castleman disease into diffuse large B-cell lymphoma: A case report from Nepal.
    Gupta A; Anand A; Hussain SH; Shah R; Ranjan R; Subedi V; Baral A; Mishra A; Pradhan A; Dulal S
    Clin Case Rep; 2023 Sep; 11(9):e7903. PubMed ID: 37705586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of acute progressive diffuse interstitial lung disease preceding idiopathic multicentric Castleman disease.
    Nabeya D; Yoshimatsu Y; Fujiwara H
    Respir Med Case Rep; 2020; 31():101216. PubMed ID: 32995258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A challenging diagnosis of idiopathic multicentric Castleman disease with complex systemic presentation: A case report.
    Strach M; Kuszmiersz P; Chmura Ł; Korkosz M
    Clin Case Rep; 2023 Oct; 11(10):e7981. PubMed ID: 37854256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Plasma-Cell Type Castleman Disease Masquerading As Hodgkin Lymphoma: A Case Report.
    Ekwere TA; Eziagu UB
    J Lab Physicians; 2020 Dec; 12(3):225-229. PubMed ID: 33268942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
    Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
    PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HHV-8 Related immunological and hematological diseases].
    Blaison F; Galtier J; Parrens M; Viallard JF; Boutboul D
    Rev Med Interne; 2022 May; 43(5):301-311. PubMed ID: 34895767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?
    Ha G; Kwong K; Tanaka B; Nishimura Y; Chong C
    Eur J Case Rep Intern Med; 2023; 10(7):003904. PubMed ID: 37455698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Castleman Disease.
    Wang W; Medeiros LJ
    Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicentric Castlemans disease. Symptoms, diagnostics and therapy].
    Adam Z; Řehák Z; Adamová Z; Koukalová R; Pour L; Krejčí M; Boichuk I; Sandecká V; Krejčí M; Štork M; Ševčíková S; Král Z
    Vnitr Lek; 2022; 68(1):41-53. PubMed ID: 35459346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary effusion lymphoma metachronous to multicentric Castleman disease in an immunocompetent patient.
    Parente P; Zanelli M; Zizzo M; Covelli C; Carosi I; Ascani S; Graziano P
    Pathol Res Pract; 2020 Jul; 216(7):153024. PubMed ID: 32534717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical behavior of localized and multicentric Castleman disease.
    Herrada J; Cabanillas F; Rice L; Manning J; Pugh W
    Ann Intern Med; 1998 Apr; 128(8):657-62. PubMed ID: 9537940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
    Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever.
    Dunn R; Jariwal R; Venter F; Mishra S; Bhandohal J; Cobos E; Heidari A
    J Investig Med High Impact Case Rep; 2022; 10():23247096221097526. PubMed ID: 35549932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease.
    Shiroshita K; Kikuchi T; Okayama M; Kasahara H; Kamiya T; Shimizu T; Kurose N; Masaki Y; Okamoto S
    Intern Med; 2020 Dec; 59(23):3061-3065. PubMed ID: 32759587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.
    Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
    Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH
    Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.